BCEL

Atreca (BCEL)

Atreca Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BCEL

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/12	05:12	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BCEL	Atreca Inc
2024/03/12	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCEL	Atreca Inc
2024/02/07	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCEL	Atreca Inc
2024/01/06	06:57	Edgar (US Regulatory)	Form PREM14A - Preliminary proxy statements relating to merger or acquisition	NASDAQ:BCEL	Atreca Inc
2023/12/26	22:39	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BCEL	Atreca Inc
2023/12/26	22:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCEL	Atreca Inc
2023/12/26	22:30	GlobeNewswire Inc.	Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to Immunome	NASDAQ:BCEL	Atreca Inc
2023/11/15	06:30	GlobeNewswire Inc.	Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic Alternatives	NASDAQ:BCEL	Atreca Inc
2023/09/28	08:20	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BCEL	Atreca Inc
2023/09/21	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCEL	Atreca Inc
2023/09/21	21:00	GlobeNewswire Inc.	Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross	NASDAQ:BCEL	Atreca Inc
2023/09/15	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCEL	Atreca Inc
2023/08/18	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BCEL	Atreca Inc
2023/08/17	06:20	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:BCEL	Atreca Inc
2023/08/11	05:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BCEL	Atreca Inc
2023/08/11	05:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BCEL	Atreca Inc
2023/08/11	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCEL	Atreca Inc
2023/08/11	05:05	GlobeNewswire Inc.	Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring	NASDAQ:BCEL	Atreca Inc
2023/08/05	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCEL	Atreca Inc
2023/08/05	07:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BCEL	Atreca Inc
2023/07/19	22:18	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BCEL	Atreca Inc
2023/06/16	07:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCEL	Atreca Inc
2023/06/16	07:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCEL	Atreca Inc
2023/06/16	07:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCEL	Atreca Inc
2023/06/16	07:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCEL	Atreca Inc
2023/06/16	07:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCEL	Atreca Inc
2023/06/16	07:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCEL	Atreca Inc
2023/06/16	07:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BCEL	Atreca Inc
2023/06/16	05:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BCEL	Atreca Inc
2023/06/05	21:00	GlobeNewswire Inc.	Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting	NASDAQ:BCEL	Atreca Inc